Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $10.9 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• FDA approves AbbVie's Skyrizi for children with psoriatic disease
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story